The effect of smoking status on the treatment of non-small cell lung cancer with immunotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29412

Enrollment

607

Registered

2021-10-15

Start date

2021-07-05

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

inapplicable

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients older than 18 years old diagnosed with non-small cell lung cancer treated with immunotherapy and/or chemotherapy.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old or patients incapable of filling in the questionnaire.

Design outcomes

Primary

Measure	Time frame
1) Mortality 2) Progression free survival	—

Secondary

Measure	Time frame
1) Adverse effects 2) Percentage of smokers that stops smoking during treatment 3) Percentage of smokers who attempt to quit smoking during treatment 4) Percentage of former/never smokers who (re)start smoking during treatment	—

Contacts

Public ContactM. de Kruif

Zuyderland MC

polilonggeneeskunde@zuyderland.nl088 – 459 9706

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)